Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Allianz Real Estate in connection with a joint venture with Heimstaden Bostad
Mandate

Vinge has advised Allianz Real Estate in connection with a joint venture with Heimstaden Bostad

January 31, 2022 Real Estate and Construction M&A Banking and Finance

Vinge has assisted Allianz Real Estate in connection with an investment of SEK 7.9 billion in Heimstaden Bostad’s Swedish portfolio, which was recently acquired from Akelius, through the formation of a joint venture. The portfolio consists of centrally located properties in Malmö and Stockholm with a value of SEK 30.4 billion.

Vinge’s team consisted of Assur Badur, Karolina Cohrs and Frida Ställborn (Real Estate), Joacim Rydergård and Clara Sohlberg (Private M&A), and Mikael Ståhl and Arvid Weimers (financing).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026